nifedipine has been researched along with glucagon in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (37.04) | 18.7374 |
| 1990's | 11 (40.74) | 18.2507 |
| 2000's | 4 (14.81) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashiguchi, M; Hashiguchi, T; Kanazawa, M; Miyazaki, T; Sakai, S; Tosaka, T | 1 |
| Ogihara, M | 2 |
| Kokot, F; Wnuk, R | 1 |
| Chiasson, JL; Larochelle, P; Parent, R | 1 |
| Gusmini, G; Lombardi, C; Rangoni, G; Spedini, C | 1 |
| Heidland, A; Hörl, WH; Riegel, W | 1 |
| Chernow, B; Horowitz, M; Zaritsky, AL | 1 |
| Altin, JG; Bygrave, FL | 1 |
| Boillot, J; Comoy, E; Denjean, A; Derrieux, C; Legrand, A; Lockhart, A; Martre, H; Raffestin, B | 1 |
| Abadie, E; Fiet, J; Gauville, C; Passa, P; Tabuteau, F; Villette, JM | 1 |
| Kobayashi, T; Nihei, J; Ohneda, A | 1 |
| Buysschaert, M; Charles, S; Ketelslegers, JM; Lambert, AE | 1 |
| Goto, Y; Hamada, M; Kai, Y; Toyota, T; Umezu, M | 1 |
| Francini, F; Gagliardino, JJ | 1 |
| Ekins, BR; Frye, G; Khasigian, PA; Mullen, JT; Walter, FG | 1 |
| Fant, JS; Fiser, RT; James, LP; Kearns, GL | 1 |
| Adner, N; Gutniak, M; Holst, JJ; Svartberg, J | 1 |
| Prentki, M; Roche, E; Schlegel, W; Susini, S | 1 |
| Yada, T; Yaekura, K; Yanagida, K | 1 |
| Buteau, J; Prentki, M; Roduit, R; Susini, S | 1 |
| O'Neil, MG; Papadopoulos, J | 1 |
| Bhargava, KK; Gupta, S; Ito, Y; McCuskey, RS; Palestro, CJ; Rajvanshi, P; Slehria, S; Sokhi, RP | 1 |
| Eliasson, L; Galvanovskis, J; Göpel, S; Kanno, T; Ma, XS; Rorsman, P; Salehi, A; Zhang, Q | 1 |
| Aynsley-Green, A; Hussain, K; Stanley, CA | 1 |
| Bryan, J; Harmon, JS; Oseid, EA; Robertson, RP; Slucca, M | 1 |
| Gilbert, C; Güemes, M; Hinchey, L; Hussain, K; Morgan, K; Shah, P; Silvera, S | 1 |
3 review(s) available for nifedipine and glucagon
| Article | Year |
|---|---|
[Effects of calcium antagonist drugs on glucide metabolism].
Topics: Animals; Calcium Channel Blockers; Diabetes Mellitus; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Mice; Middle Aged; Nifedipine | 1988 |
Glucagon antagonism of calcium channel blocker-induced myocardial dysfunction.
Topics: Animals; Coronary Circulation; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Glucagon; Hemodynamics; Infusion Pumps; Male; Myocardial Contraction; Nifedipine; Rats; Verapamil | 1988 |
Medications used in the treatment of hypoglycemia due to congenital hyperinsulinism of infancy (HI).
Topics: Congenital Hyperinsulinism; Diazoxide; Gastrointestinal Agents; Glucagon; Humans; Hypoglycemia; Infant; Nifedipine; Octreotide; Vasodilator Agents | 2004 |
3 trial(s) available for nifedipine and glucagon
| Article | Year |
|---|---|
Effects of nifedipine on responses to exercise in normal subjects.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adult; Blood Glucose; Blood Pressure; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Heart Rate; Humans; Hydroxybutyrates; Insulin; Lactates; Lactic Acid; Male; Maximal Voluntary Ventilation; Middle Aged; Nifedipine; Norepinephrine; Physical Exertion; Pulmonary Gas Exchange; Pyruvates; Pyruvic Acid; Respiration; Time Factors; Triglycerides | 1985 |
[Effects of nifedipine on carbohydrate metabolism in the non-insulin dependent diabetic].
Topics: Adult; Aged; Arginine; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Male; Middle Aged; Nifedipine; Prospective Studies; Random Allocation | 1985 |
The ethanol augmentation of glucose-induced insulin secretion is abolished by calcium antagonism with nifedipine: no evidence for a role of glucagon-like peptide-1 (GLP-1).
Topics: Adult; C-Peptide; Calcium Channel Blockers; Ethanol; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Nifedipine; Peptide Fragments; Protein Precursors | 1998 |
21 other study(ies) available for nifedipine and glucagon
| Article | Year |
|---|---|
Phenytoin partially antagonized L-type Ca2+ current in glucagon-secreting tumor cells (ITC-1).
Topics: Animals; Barium; Calcium; Calcium Channels; Cricetinae; Electrophysiology; Glucagon; Lanthanum; Membrane Potentials; Mesocricetus; Nifedipine; Phenytoin; Tumor Cells, Cultured | 1992 |
Effects of nifedipine and nicardipine on glucagon-stimulated gluconeogenesis in primary cultures of rat hepatocytes.
Topics: Animals; Cells, Cultured; Cyclic AMP; Glucagon; Gluconeogenesis; Glucose; Liver; Male; Nicardipine; Nifedipine; Rats; Rats, Inbred Strains | 1992 |
[Essential hypertension. Treatment with nifedipine and levels of insulin, glucagon, gastrin and prolactin].
Topics: Adult; Female; Gastrins; Glucagon; Humans; Hypertension; Insulin; Male; Middle Aged; Nifedipine; Prolactin | 1991 |
Hemodynamic and endocrine effects of acute and chronic administration of nifedipine.
Topics: Aldosterone; Arginine; Blood Pressure; Cardiac Output; Endocrine Glands; Female; Glucagon; Glycated Hemoglobin; Hemodynamics; Humans; Hypertension; Insulin; Male; Middle Aged; Nifedipine; Regional Blood Flow; Renin; Time Factors | 1989 |
Long-term effects of nifedipine on carbohydrate and lipid metabolism in hypertensive hemodialyzed patients.
Topics: Adult; Blood Glucose; Cholesterol; Citrates; Citric Acid; Female; Glucagon; Humans; Hypertension, Renal; Insulin; Ketoglutaric Acids; Lactates; Lactic Acid; Lipids; Long-Term Care; Male; Middle Aged; Nifedipine; Pyruvates; Pyruvic Acid; Renal Dialysis; Triglycerides | 1986 |
The influx of Ca2+ induced by the administration of glucagon and Ca2+-mobilizing agents to the perfused rat liver could involve at least two separate pathways.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Calcium; Diltiazem; Epidermal Growth Factor; Glucagon; Liver; Male; Neomycin; Nifedipine; Perfusion; Rats; Rats, Inbred Strains; Verapamil | 1987 |
Effects of Ca antagonists, nifedipine, niludipine and verapamil, on endocrine function of the pancreas.
Topics: Animals; Dogs; Dose-Response Relationship, Drug; Glucagon; Insulin; Insulin Secretion; Islets of Langerhans; Nifedipine; Pyridines; Verapamil | 1983 |
Hyperglycaemic effect of nifedipine.
Topics: Adult; Blood Glucose; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Nifedipine; Pyridines; Stimulation, Chemical | 1981 |
[Effect of nicardipine (YC-93), a calcium antagonist, on hormonal secretion of the pancreas (author's transl)].
Topics: Animals; Calcium; Glucagon; In Vitro Techniques; Insulin; Insulin Secretion; Male; Nicardipine; Nifedipine; Pancreas; Pyridines; Rats | 1981 |
Nifedipine and nicardipine potentiate glucagon-stimulated glycogenolysis in primary cultures of rat hepatocytes.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Caffeine; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Glucagon; Glycogen; Liver; Male; Nicardipine; Nifedipine; Papaverine; Rats; Rats, Wistar | 1993 |
An in vitro model suitable for studying insulin secretion in amphibians.
Topics: Acetylcholine; Amphibians; Animals; Arginine; Bufo arenarum; Caproates; Glucagon; Glucose; In Vitro Techniques; Insulin; Insulin Antagonists; Insulin Secretion; Keto Acids; Male; Nifedipine; Pancreatin; Potassium; Radioimmunoassay; Somatostatin; Swine; Tolbutamide | 1995 |
Amelioration of nifedipine poisoning associated with glucagon therapy.
Topics: Adult; Calcium Chloride; Drug Therapy, Combination; Glucagon; Humans; Hypotension; Male; Nifedipine; Poisoning | 1993 |
The use of glucagon in nifedipine poisoning complicated by clonidine ingestion.
Topics: Adolescent; Antidotes; Antihypertensive Agents; Calcium Channel Blockers; Clonidine; Drug Interactions; Drug Overdose; Female; Glucagon; Humans; Nifedipine; Poisoning | 1997 |
Glucose and glucoincretin peptides synergize to induce c-fos, c-jun, junB, zif-268, and nur-77 gene expression in pancreatic beta(INS-1) cells.
Topics: Animals; Cell Line; Cyclic AMP; DNA-Binding Proteins; Drug Synergism; Early Growth Response Protein 1; Gastric Inhibitory Polypeptide; Gene Expression Regulation; Genes, fos; Genes, Immediate-Early; Genes, jun; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Immediate-Early Proteins; Islets of Langerhans; Neuropeptides; Nifedipine; Peptide Fragments; Pituitary Adenylate Cyclase-Activating Polypeptide; Protein Precursors; Recombinant Proteins; Tetradecanoylphorbol Acetate; Thionucleotides; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Zinc Fingers | 1998 |
PACAP and GLP-1 protect islet beta-cells against Ca2+ toxicity induced by high K+.
Topics: Animals; Arginine; Calcium; Cells, Cultured; Glucagon; Glucagon-Like Peptide 1; Glucose; Islets of Langerhans; Neuropeptides; Nifedipine; Peptide Fragments; Pituitary Adenylate Cyclase-Activating Polypeptide; Potassium Chloride; Protein Precursors; Rats; Rats, Wistar; Tolbutamide | 1998 |
Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells.
Topics: Androstadienes; Animals; Chromones; DNA; DNA-Binding Proteins; Duodenum; Enzyme Activation; Enzyme Inhibitors; Genes, Homeobox; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Islets of Langerhans; Morpholines; Nifedipine; Pancreas; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Potassium Chloride; Protein Precursors; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Transcription Factor AP-1; Transcription Factors; Tumor Cells, Cultured; Wortmannin | 1999 |
Utilization of a glucagon infusion in the management of a massive nifedipine overdose.
Topics: Administration, Oral; Calcium Channel Blockers; Delayed-Action Preparations; Emergency Treatment; Gastric Lavage; Glucagon; Humans; Hypotension; Infusions, Intravenous; Male; Middle Aged; Nifedipine; Suicide, Attempted | 2000 |
Hepatic sinusoidal vasodilators improve transplanted cell engraftment and ameliorate microcirculatory perturbations in the liver.
Topics: Adrenergic alpha-Antagonists; Animals; Calcitonin Gene-Related Peptide; Calcium Channel Blockers; Dipeptidyl Peptidase 4; Glucagon; Hepatocytes; Labetalol; Liver; Liver Circulation; Microcirculation; Nifedipine; Nitroglycerin; Phentolamine; Rats; Rats, Inbred F344; Rats, Mutant Strains; Splanchnic Circulation; Vasodilator Agents | 2002 |
Capacitance measurements of exocytosis in mouse pancreatic alpha-, beta- and delta-cells within intact islets of Langerhans.
Topics: Action Potentials; Animals; Calcium Channels, L-Type; Calcium Channels, N-Type; Calcium Channels, R-Type; Cells, Cultured; Electric Capacitance; Electrophysiology; Exocytosis; Glucagon; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Membrane Potentials; Mice; Mice, Inbred Strains; Microscopy, Electron, Transmission; Nifedipine; omega-Conotoxin GVIA; Patch-Clamp Techniques; Pertussis Toxin; Secretory Vesicles; Somatostatin-Secreting Cells; Spider Venoms | 2004 |
ATP-sensitive K+ channel mediates the zinc switch-off signal for glucagon response during glucose deprivation.
Topics: Animals; Calcium Channels; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Secreting Cells; Humans; Hypoglycemia; Insulin; Insulin Secretion; KATP Channels; Male; Mice; Mice, Inbred C57BL; Nifedipine; Rats; Signal Transduction; Zinc | 2010 |
Assessment of Nifedipine Therapy in Hyperinsulinemic Hypoglycemia due to Mutations in the ABCC8 Gene.
Topics: Calcium Channel Blockers; Child, Preschool; Cohort Studies; Congenital Hyperinsulinism; Diazoxide; Drug Therapy, Combination; Female; Gastrointestinal Agents; Glucagon; Humans; Infant; Male; Nifedipine; Octreotide; Prospective Studies; Starch; Sulfonylurea Receptors; Treatment Outcome | 2017 |